Progenitor cells in arteriosclerosis: good or bad guys?

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Vascular Biology

Background:

• Progenitor cells, including endothelial progenitor cells (EPCs) and smooth muscle progenitors (SMPs), are implicated in vascular diseases.
• These cells can contribute to both arterial repair and pathological lesion formation in conditions like atherosclerosis and transplant arteriosclerosis.
• Their dual role suggests a complex involvement in the pathogenesis of arteriosclerosis.

Purpose of the Study:

• To review current understanding of progenitor cell roles in arteriosclerosis.
• To focus on progenitor cell involvement in lesion formation and plaque stability.
• To discuss controversies regarding progenitor cell origins, frequency, and impact.

Main Methods:

• Literature review and synthesis of existing research on progenitor cells in arteriosclerosis.
• Analysis of studies investigating the functions of endothelial and smooth muscle progenitors.
• Discussion of regulatory networks controlling progenitor cell differentiation.

Main Results:

• Endothelial progenitor cells (EPCs) can repair arteries but also contribute to atherosclerotic plaque instability.
• Smooth muscle progenitors (SMPs) may promote restenosis but also stabilize plaques by producing extracellular matrix.
• Both cell types act as a "double-edged sword" in arteriosclerosis pathogenesis.

Conclusions:

• Understanding the regulatory networks controlling EPC and SMP differentiation is crucial for basic research.
• This knowledge is fundamental for developing improved therapeutic strategies for atherosclerosis.
• Further research is needed to clarify progenitor cell origins, frequency, and precise impact on disease progression.